1462P Clinical outcome of patients with non-clear metastatic renal cell carcinoma treated with pembrolizumab-axitinib combination: NEMESIA (non-clear metastatic renal cell carcinoma pembrolizumab axitinib) study, a subgroup analysis of I-RARE observational study (Meet-URO 23a)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 33; pp. S1214 - S1215
Main Authors Stellato, M., Buti, S., Maruzzo, M., Bersanelli, M., Ermacora, P., Maiorano, B.A., Prati, V., De Giorgi, U.F.F., Pierantoni, F., Malgeri, A., Mennitto, A., Cavo, A., Vitale, M.G., Santoni, M., Carella, C., Procopio, G., Verzoni, E., Santini, D.
Format Journal Article
LanguageEnglish
Published 01.09.2022
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.1565